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Abstract — Drug resistance represents one of the major challenges to effective chemotherapeutic interventions 
against cancer. There is an urgent need for novel agents that could increase sensitivity to chemotherapy in 
cancer cells. Potential bioactive effects exerted by natural compounds led us to test the cytotoxic properties 
of anthocyanidins in human colorectal carcinoma metastatic cells and their role on the expression of genes 
involved in the development of drug resistance. 
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_____________________________________________________________________ 
1 BACKGROUND
Colon cancer is the third most common cancer in men and the second in women. It  is the second 
leading cause of cancer death in the developed world. Lifetime risk of developing colon cancer has 
been estimated at 1:20 (5%).
Together with surgery, chemotherapy is the cornerstone treatment for metastatic colorectal cancer. 
However, a high percentage of drug-resistant tumor forms represents a major challenge to modern 
medicine calling for new strategies and compounds able to reverse drug resistance.
Bioactive dietary components have raised a lot of interest recently in the field of cancer research. Many 
of them show anticancer properties and are seen as potential preventive and therapeutic agents.
2 OBJECTIVES
To assess the possible synergy of anthocyanidins* with cytotoxic drugs, especially their effect on the 
expression of certain genes involved in the development of drug resistance.
S. Passamonti, S. Gustincich, T. Lah Turnšek, B. Peterlin, R. Pišot, P. Storici (Eds.) 
CONFERENCE PROCEEDINGS with an analysis of innovation management 
and knowledge transfer potential for a smart specialization strategy 
ISBN 978-88-8303-572-2 / e-ISBN  978-88-8303-573-9. EUT, 2014.
CROSS-BORDER ITALY-SLOVENIA 
BIOMEDICAL RESEARCH:
ARE WE READY FOR HORIZON 2020?
247
• plant pigments belonging to the group of dietary flavonoids, widely present in fruits, vegetables and 
flowers; anthocyanidins have been reported to exert anti-inflammatory and antioxidant activity in 
normal cells and numerous effects in cancer cells (eg. interaction with extrusion pumps, interaction 
with MAPKS and alteration of signal transduction pathways involved in cell proliferation, angiogenesis 
and apoptosis, reduction of GSTP expression, inhibition of topoisomerase I and II).
3 APPROACH & METHODS
General approach 
Assessing the effect of long-term treatment with anthocyanidins on the expression of certain genes 
involved in the development of drug resistance using human cell culture models.
Methods
• Cells: metastatic colon cancer cells resistant to doxorubicin 
• Treatment: anthocyanidins
• Cytotoxicity test (Alamar Blue) 
• Uptake studies (doxorubicin uptake)
• Western blot 
• qPCR 
• Immunocytochemistry 
• Cell cycle analysis – flow cytometry
4 RESULTS
• Drug resistance - we have identified conditions under which the tested anthocyanidins increase 
sensitivity of drug-resistant colon cancer cells. Mechanistic studies are ongoing. 
• Cell cycle analysis - inhibition of drug-resistant cell proliferation after prolonged treatments with 
anthocyanidins was observed:
    R1=H;         R2=H  Pelargonidin
    R1=OH;      R2=H           Cyanidin
    R1=OH;      R2=OH        Delphinidin
    R1=OCH3;  R2=H           Peonidin
    R1=OCH3;  R2=OH        Petunidin
    R1=OCH3;  R2= OCH3  Malvidin
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Long-term treatment with anthocyanidins decreases the number of cells in S phase while increasing the 
number of cells in G2/M phase suggesting inhibition of cell proliferation through induction of cell cycle 
arrest in G2 checkpoint phase 
5 POTENTIAL NEW PRODUCTS & SERVICES
• Oral nutritional supplements for colon cancer patients
• “Local adjuvant therapy” for colon cancer patients
6 CURRENT COLLABORATIONS
With other researchers 
Collaboration with:
• Maja Čemažar and Mitja Rak (Trans2Care, PP12, University of Primorska, Faculty of Health Sciences, 
Slovenia)
• Vanessa Nicolin (University of Trieste, Dep. of Medicine, Surgery and Health Sciences, Italy)
With associations 
Collaboration with LILT (Italian ligue for the fight against cancer) and ASS1 (health agency in Trieste, 
Italy)
7 CONTACT OR COLLABORATIONS NEEDED
Collaborators for in vivo studies in mouse models of colon cancer.
8 COMMUNICATION TOOLS
• www.trans2care.eu
9 FUNDS NEEDED
9.1 For basic research (investigation of biological mechanisms): 100.000 €  
9.2 For applied research (solutions for real-world problems): 350.000 €
9.2 For pilot & demonstrator activities (to develop a prototype): 500.000 €
10 CONCLUSION
The results of the ongoing study should help to understand if anthocyanidins can be used as sensitizing 
agents in metastatic colorectal cancer therapy.
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